In 2023, the market size value per capita for hormones in dosage except contraceptives and antibiotics in China was $5.80. The forecast indicates a steady growth from $5.98 in 2024 to $6.73 in 2028. This portrays a consistent upward trend in the market size value per capita.

Year-on-year growth from 2024 to 2028 averages approximately 3% annually. The Compound Annual Growth Rate (CAGR) over the five-year forecast period is anticipated to be around 3.0%, reflecting a stable increase in the market size value over time.

Future trends to watch for include:

Technological advancements in hormone production, enhancing efficiency and reducing costs.
Increased adoption of hormone therapies driven by rising health awareness and expanding healthcare access in China.
Potential regulatory changes impacting market dynamics and influencing consumer demand.